Skip to content
EvidenceHelixEvidenceLib · Scientific Encyclopedia
⌘ K

Scientific library

EvidenceLib encyclopediaAll articles A–Z2,835
Books209
All textbooksMedical textbooksHuman anatomyOrganisms & biodiversityOther sciences
Open-access articles1,406Cancer study catalog458How it is made

My workspace this browser

Saved pages0Notes & annotations0

Recently viewed

Explore by field

Cancer and Oncology182Genetics and Genomics170Neuroscience185Cardiovascular Medicine180Immunology142Pharmacology173Molecular Biology161Infectious Diseases150Rare and Inherited Diseases181Clinical Research173Anatomy and Physiology613Drugs and Chemicals621Psychiatry and Psychology185Public Health and Nutrition178Diagnostics and Medical Technology125Respiratory Medicine113Digestive System and Liver91Metabolism and Endocrine Disease177Bones, Joints, Muscles and Skin213Kidney, Urology and Women's Health173Eye, Ear, Nose and Throat55
Plans & pricingCompare EvidenceHelix workspace plans
Library›Open textbooks›One-session treatment compared with multisession CBT in children aged 7–16 years with specific phobias: the ASPECT non-inferiority RCT›References

Continue where you left off ()

GO BEYOND THE PAGEReading is just the beginning.

Turn scientific reading into research. Compare studies, examine evidence, and organize your findings in EvidenceHelix Workspace.

Explore Research Workspace →

One-session treatment compared with multisession CBT in children aged 7–16 years with specific phobias: the ASPECT non-inferiority RCT · References

References

CC BY 4.0 · National Institute for Health and Care Research · approximately 15 min read

  1. Wright B, Tindall L, Scott AJ, Lee E, Cooper C, Bee P, et al. One session treatment (OST) is equivalent to multi-session cognitive behavioural therapy (CBT) in children with specific phobias (ASPECT): results from a national non-inferiority randomized controlled trial [published online ahead of print August 1 2022]. J Child Psychol Psychiatry 2022. 10.1111/jcpp.13665
  2. Wang HI, Wright B, Tindall L, Cooper C, Biggs K, Lee E, et al. Cost and effectiveness of one session treatment (OST) for children and young people with specific phobias compared to multi-session cognitive behavioural therapy (CBT): results from a randomised controlled trial. BMJ Psychiatry 2022;22:547. 10.1186/s12888-022-04192-8
  3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Washington, DC: American Psychiatric Association; 2013. 10.1176/appi.books.9780890425596
  4. Hofmann SG. Cognitive processes during fear acquisition and extinction in animals and humans: implications for exposure therapy of anxiety disorders. Clin Psychol Rev 2008;28:199–210. 10.1016/j.cpr.2007.04.00917532105
  5. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005;62:593–602. 10.1001/archpsyc.62.6.59315939837
  6. Stinson FS, Dawson DA, Patricia Chou S, Smith S, Goldstein RB, June Ruan W, Grant BF. The epidemiology of DSM-IV specific phobia in the USA: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Psychol Med 2007;37:1047–59. 10.1017/S003329170700008617335637
  7. Comer JS, Blanco C, Hasin DS, Liu SM, Grant BF, Turner JB, Olfson M. Health-related quality of life across the anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). J Clin Psychiatry 2011;72:43–50. 10.4088/JCP.09m05094blu20816036
  8. Ialongo N, Edelsohn G, Werthamer-Larsson L, Crockett L, Kellam S. The significance of self-reported anxious symptoms in first grade children: prediction to anxious symptoms and adaptive functioning in fifth grade. J Child Psychol Psychiatry 1995;36:427–37. 10.1111/j.1469-7610.1995.tb01300.x7782406
  9. Ollendick TH, March JS. Phobic and Anxiety Disorders in Children and Adolescents: A Clinician’s Guide to Effective Psychosocial and Pharmacological Interventions. Oxford: Oxford University Press; 2004. 10.1093/med:psych/9780195135947.001.0001
  10. Bittner A, Egger HL, Erkanli A, Jane Costello E, Foley DL, Angold A. What do childhood anxiety disorders predict? J Child Psychol Psychiatry Allied Discip 2007;48:1174–83. 10.1111/j.1469-7610.2007.01812.x
  11. Lieb R, Miché M, Gloster AT, Beesdo-Baum K, Meyer AH, Wittchen HU. Impact of specific phobia on the risk of onset of mental disorders: a 10-year prospective-longitudinal community study of adolescents and young adults. Depress Anxiety 2016;33:667–75. 10.1002/da.2248726990012
  12. Anderson JK, Howarth E, Vainre M, Jones PB, Humphrey A. A scoping literature review of service-level barriers for access and engagement with mental health services for children and young people. Child Youth Serv Rev 2017;77:164–76. 10.1016/j.childyouth.2017.04.017
  13. Crenna-Jennings W, Hutchinson J. Access to Child and Adolescent Mental Health Services in 2019. 2020. URL: https://epi.org.uk/publications-and-research/access-to-child-and-adolescent-mental-health-services-in-2019/ (accessed 19 March 2021).
  14. Rocks S, Glogowska M, Stepney M, Tsiachristas A, Fazel M. Introducing a single point of access (SPA) to child and adolescent mental health services in England: a mixed-methods observational study. BMC Health Serv Res 2020;20:623. 10.1186/s12913-020-05463-432641117
  15. Sayal K. Annotation: pathways to care for children with mental health problems. J Child Psychol Psychiatry 2006;47:649–59. 10.1111/j.1469-7610.2005.01543.x16790000
  16. Kendall PC, Robin JA, Hedtke KA, Suveg C, Flannery-Schroeder E, Gosch E. Considering CBT with anxious youth? Think exposures. Cogn Behav Pract 2005;12:136–48. 10.1016/S1077-7229(05)80048-3
  17. Kendall PC, Hedtke KA. Cognitive-behavioral Therapy for Anxious Children: Therapist Manual. 3rd edn. Ardmore, PA: Workbook Pub Inc.; 2006.
  18. Butler AC, Chapman JE, Forman EM, Beck AT. The empirical status of cognitive-behavioral therapy: a review of meta-analyses. Clin Psychol Rev 2006;26:17–31. 10.1016/j.cpr.2005.07.00316199119
  19. Davis III TE, Ollendick TH. Empirically supported treatments for specific phobia in children: do efficacious treatments address the components of a phobic response? Clin Psychol Sci Pract 2005;12:144–60. 10.1093/clipsy.bpi018
  20. Hofmann SG, Asnaani A, Vonk IJ, Sawyer AT, Fang A. The efficacy of cognitive behavioral therapy: a review of meta-analyses. Cognit Ther Res 2012;36:427–40. 10.1007/s10608-012-9476-1
  21. Hudson JL, Rapee RM, Lyneham HJ, McLellan LF, Wuthrich VM, Schniering CA. Comparing outcomes for children with different anxiety disorders following cognitive behavioural therapy. Behav Res Ther 2015;72:30–7. 10.1016/j.brat.2015.06.00726164621
  22. Aschim B, Lundevall S, Martinsen EW, Frich JC. General practitioners’ experiences using cognitive behavioural therapy in general practice: a qualitative study. Scand J Prim Health Care 2011;29:176–80. 10.3109/02813432.2011.59558221861599
  23. Wiebe E, Greiver M. Using cognitive behavioural therapy in practice: qualitative study of family physicians’ experiences. Can Fam Physician 2005;51:992–3.16926952
  24. Stallard P, Udwin O, Goddard M, Hibbert S. The availability of cognitive behaviour therapy within specialist child and adolescent mental health services (CAMHS): a national survey. Behav Cogn Psychother 2007;35:501. 10.1017/S1352465807003724
  25. van der Gaag M. The efficacy of CBT for severe mental illness and the challenge of dissemination in routine care. World Psychiatry 2014;13:257–8. 10.1002/wps.2016225273295
  26. Cavanagh K. Geographic inequity in the availability of cognitive behavioural therapy in England and Wales: a 10-year update. Behav Cogn Psychother 2014;42:497–501. 10.1017/S135246581300056823829940
  27. Shapiro DA, Cavanagh K, Lomas H. Geographic inequity in the availability of cognitive behavioural therapy in England and Wales. Behav Cogn Psychother 2003;31:185. 10.1017/S1352465803002066
  28. Ollendick TH, Ryan SM, Capriola-Hall NN, Austin KE, Fraire M. Have phobias, will travel: addressing one barrier to the delivery of an evidence-based treatment. Behav Ther 2018;49:594–603. 10.1016/j.beth.2017.11.00329937260
  29. de Haan AM, Boon AE, de Jong JT, Hoeve M, Vermeiren RR. A meta-analytic review on treatment dropout in child and adolescent outpatient mental health care. Clin Psychol Rev 2013;33:698–711. 10.1016/j.cpr.2013.04.00523742782
  30. Wergeland GJ, Fjermestad KW, Marin CE, Haugland BS, Silverman WK, Öst LG, et al. Predictors of dropout from community clinic child CBT for anxiety disorders. J Anxiety Disord 2015;31:1–10. 10.1016/j.janxdis.2015.01.00425637909
  31. Zlomke K, Davis TE. One-session treatment of specific phobias: a detailed description and review of treatment efficacy. Behav Ther 2008;39:207–23. 10.1016/j.beth.2007.07.00318721635
  32. Davis TE, Ollendick TH, Öst LG. One-session treatment of specific phobias in children: recent developments and a systematic review. Annu Rev Clin Psychol 2019;15:233–56. 10.1146/annurev-clinpsy-050718-09560830550722
  33. Ollendick TH, Ost LG, Reuterskiöld L, Costa N, Cederlund R, Sirbu C, et al. One-session treatment of specific phobias in youth: a randomized clinical trial in the United States and Sweden. J Consult Clin Psychol 2009;77:504–16. 10.1037/a001515819485591
  34. Öst LG, Svensson L, Hellström K, Lindwall R. One-session treatment of specific phobias in youths: a randomized clinical trial. J Consult Clin Psychol 2001;69:814–24. 10.1037/0022-006X.69.5.81411680558
  35. Ryan SM, Strege MV, Oar EL, Ollendick TH. One session treatment for specific phobias in children: comorbid anxiety disorders and treatment outcome. J Behav Ther Exp Psychiatry 2017;54:128–34. 10.1016/j.jbtep.2016.07.01127474792
  36. Singal AG, Higgins PD, Waljee AK. A primer on effectiveness and efficacy trials. Clin Transl Gastroenterol 2014;5:e45. 10.1038/ctg.2013.1324384867
  37. Ollendick TH, Halldorsdottir T, Fraire MG, Austin KE, Noguchi RJ, Lewis KM, et al. Specific phobias in youth: a randomized controlled trial comparing one-session treatment to a parent-augmented one-session treatment. Behav Ther 2015;46:141–55. 10.1016/j.beth.2014.09.00425645164
  38. Becker ES, Rinck M, Türke V, Kause P, Goodwin R, Neumer S, Margraf J. Epidemiology of specific phobia subtypes: findings from the Dresden Mental Health Study. Eur Psychiatry 2007;22:69–74. 10.1016/j.eurpsy.2006.09.00617157482
  39. Kim SJ, Kim BN, Cho SC, Kim JW, Shin MS, Yoo HJ, Kim HW. The prevalence of specific phobia and associated cormobid features in children and adolescents. J Anxiety Disord 2010;24:629–34. 10.1016/j.janxdis.2010.04.00420439148
  40. Castagna PJ, Davis TE, Lilly ME. The behavioral avoidance task with anxious youth: a review of procedures, properties, and criticisms. Clin Child Fam Psychol Rev 2017;20:162–84. 10.1007/s10567-016-0220-327995381
  41. Wright BD, Cooper C, Scott AJ, Tindall L, Ali S, Bee P, et al. Clinical and cost-effectiveness of one-session treatment (OST) versus multisession cognitive-behavioural therapy (CBT) for specific phobias in children: protocol for a non-inferiority randomised controlled trial. BMJ Open 2018;8:e025031. 10.1136/bmjopen-2018-025031
  42. Hayward E, Solaiman K, Bee P, Barr A, Edwards H, Lomas J, et al. One-session treatment for specific phobias: barriers, facilitators and acceptability as perceived by children & young people, parents, and clinicians. PLOS ONE 2022;17:e0274424. 10.1371/journal.pone.027442436107883
  43. Schulz KF, Altman DG, Moher D, CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. Trials 2010;11:32. 10.1186/1745-6215-11-3220334632
  44. Wright B, Marshall D, Adamson J, Ainsworth H, Ali S, Allgar V, et al. Social Stories™ to alleviate challenging behaviour and social difficulties exhibited by children with autism spectrum disorder in mainstream schools: design of a manualised training toolkit and feasibility study for a cluster randomised controlled trial with nested qualitative and cost-effectiveness components. Health Technol Assess 2016;20(6). 10.3310/hta20060
  45. Wright B, Marshall D, Collingridge Moore D, Ainsworth H, Hackney L, Adamson J, et al. Autism Spectrum Social Stories In Schools Trial (ASSSIST): study protocol for a feasibility randomised controlled trial analysing clinical and cost-effectiveness of Social Stories in mainstream schools. BMJ Open 2014;4:e005952. 10.1136/bmjopen-2014-005952
  46. Lyneham HJ, Rapee RM. Agreement between telephone and in-person delivery of a structured interview for anxiety disorders in children. J Am Acad Child Adolesc Psychiatry 2005;44:274–82. 10.1097/00004583-200503000-0001215725972
  47. Silverman WK, Albano AM. Anxiety Disorders Interview Schedule (ADIS-IV) Child and Parent Interview Schedules. Albany, NY: Greywind Publications; 1996.
  48. Silverman WK, Saavedra LM, Pina AA. Test-retest reliability of anxiety symptoms and diagnoses with the Anxiety Disorders Interview Schedule for DSM-IV: child and parent versions. J Am Acad Child Adolesc Psychiatry 2001;40:937–44. 10.1097/00004583-200108000-0001611501694
  49. Langley AK, Bergman RL, McCracken J, Piacentini JC. Impairment in childhood anxiety disorders: preliminary examination of the child anxiety impact scale-parent version. J Child Adolesc Psychopharmacol 2004;14:105–14. 10.1089/10445460477384054415142397
  50. Langley AK, Falk A, Peris T, Wiley JF, Kendall PC, Ginsburg G, et al. The child anxiety impact scale: examining parent- and child-reported impairment in child anxiety disorders. J Clin Child Adolesc Psychol 2014;43:579–91. 10.1080/15374416.2013.81731123915200
  51. Chorpita BF, Moffitt CE, Gray J. Psychometric properties of the Revised Child Anxiety and Depression Scale in a clinical sample. Behav Res Ther 2005;43:309–22. 10.1016/j.brat.2004.02.00415680928
  52. Law D, Jacob J. Goals and Goal Based Outcomes (GBOs). 3rd edn. London: CAMHS Press; 2013.
  53. The EuroQol Group. EuroQol – a new facility for the measurement of health-related quality of life. Health Policy 1990;16:199–208. 10.1016/0168-8510(90)90421-910109801
  54. Stevens K, Ratcliffe J. Measuring and valuing health benefits for economic evaluation in adolescence: an assessment of the practicality and validity of the child health utility 9D in the Australian adolescent population. Value Health 2012;15:1092–9. 10.1016/j.jval.2012.07.01123244812
  55. Barrett B, Byford S, Chitsabesan P, Kenning C. Mental health provision for young offenders: service use and cost. Br J Psychiatry 2006;188:541–6. 10.1192/bjp.bp.105.01010816738344
  56. Marshall D, Wright B, Allgar V, Adamson J, Williams C, Ainsworth H, et al. Social Stories in mainstream schools for children with autism spectrum disorder: a feasibility randomised controlled trial. BMJ Open 2016;6:e011748. 10.1136/bmjopen-2016-011748
  57. Wright B, Tindall L, Littlewood E, Adamson J, Allgar V, Bennett S, et al. Computerised cognitive behaviour therapy for depression in adolescents: study protocol for a feasibility randomised controlled trial. BMJ Open 2014;4:e006488. 10.1136/bmjopen-2014-006488
  58. Dolan P. Modeling valuations for EuroQol health states. Med Care 1997;35:1095–108. 10.1097/00005650-199711000-000029366889
  59. Stevens K. Valuation of the Child Health Utility 9D Index. PharmacoEconomics 2012;30:729–47. 10.2165/11599120-000000000-0000022788262
  60. Hofmann SG, Smits JA. Cognitive-behavioral therapy for adult anxiety disorders: a meta-analysis of randomized placebo-controlled trials. J Clin Psychiatry 2008;69:621–32. 10.4088/JCP.v69n041518363421
  61. Davis TE, May A, Whiting SE. Evidence-based treatment of anxiety and phobia in children and adolescents: current status and effects on the emotional response. Clin Psychol Rev 2011;31:592–602. 10.1016/j.cpr.2011.01.00121482318
  62. Davis III TE, Jenkins W, Rudy B. Empirical Status of One-session Treatment. In Davis III TE, Ollendick TH, Öst LG, editors. Intensive One-Session Treatment of Specific Phobias. New York, NY: Springer; 2012. pp. 209–26. 10.1007/978-1-4614-3253-1_11
  63. Stallard P, Myles P, Branson A. The Cognitive Behaviour Therapy Scale for Children and Young People (CBTS-CYP): development and psychometric properties. Behav Cogn Psychother 2014;42:269–82. 10.1017/S135246581300115X24495357
  64. Blackburn IM, James IA, Milne DL, Baker C, Standart S, Garland A, et al. The revised cognitive therapy scale (CTS-R): psychometric properties. Behav Cogn Psychother 2001;29:431–46. 10.1017/S1352465801004040
  65. Borrelli B. The assessment, monitoring, and enhancement of treatment fidelity in public health clinical trials. J Public Health Dent 2011;71(Suppl. 1):52–63. 10.1111/j.1752-7325.2011.00233.x
  66. Wolitzky-Taylor KB, Horowitz JD, Powers MB, Telch MJ. Psychological approaches in the treatment of specific phobias: a meta-analysis. Clin Psychol Rev 2008;28:1021–37. 10.1016/j.cpr.2008.02.00718410984
  67. Reynolds S, Wilson C, Austin J, Hooper L. Effects of psychotherapy for anxiety in children and adolescents: a meta-analytic review. Clin Psychol Rev 2012;32:251–62. 10.1016/j.cpr.2012.01.00522459788
  68. Jones B, Jarvis P, Lewis JA, Ebbutt AF. Trials to assess equivalence: the importance of rigorous methods. BMJ 1996;313:36–9. 10.1136/bmj.313.7048.368664772
  69. Altman DG. Practical Statistics for Medical Research. London: Chapman and Hall/CRC Press; 1991.
  70. Piaggio G, Elbourne DR, Pocock SJ, Evans SJ, Altman DG, CONSORT Group. Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement. JAMA 2012;308:2594–604. 10.1001/jama.2012.8780223268518
  71. Goulet-Pelletier J-C, Cousineau D. A review of effect sizes and their confidence intervals, part I: the Cohen’s d family. Quant Methods Psychol 2018;14:242–65. 10.20982/tqmp.14.4.p242
  72. Angrist JD, Imbens GW, Rubin DB. Identification of causal effects using instrumental variables. J Am Stat Assoc 1996;91:444–55. 10.1080/01621459.1996.10476902
  73. Whitehead SJ, Ali S. Health outcomes in economic evaluation: the QALY and utilities. Br Med Bull 2010;96:5–21. 10.1093/bmb/ldq03321037243
  74. NHS Improvement. National Cost Collection 2018–2019. URL: https://www.england.nhs.uk/publication/2018-19-national-cost-collection-data-publication/ (accessed January 2021).
  75. Curtis L, Burns A. Unit Costs of Health and Social Care 2018. Canterbury: PSSRU, University of Kent; 2018.
  76. NHS Digital. Prescription Cost Analysis – England, 2018. 2018. URL: https://digital.nhs.uk/data-and-information/publications/statistical/prescription-cost-analysis (accessed January 2021).
  77. National Institute for Health Care and Excellence (NICE). Developing NICE Guidelines: The Manual. [ PMG20 ]. London: NICE; 2020.
  78. Rubin DB. Statistical matching using file concatenation with adjusted weights and multiple imputations. J Bus Econ Stat 1986;4:87–94. 10.1080/07350015.1986.10509497
  79. Manca A, Hawkins N, Sculpher MJ. Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility. Health Econ 2005;14:487–96. 10.1002/hec.94415497198
  80. Glick HA, Doshi JA, Sonnad SS, Polsky D. Economic Evaluation in Clinical Trials. Oxford: Oxford University Press; 2014. 10.1093/med/9780199685028.001.0001
  81. Hoch JS, Briggs AH, Willan AR. Something old, something new, something borrowed, something blue: a framework for the marriage of health econometrics and cost-effectiveness analysis. Health Econ 2002;11:415–30. 10.1002/hec.67812112491
  82. Briggs AH, Wonderling DE, Mooney CZ. Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation. Health Econ 1997;6:327–40. 10.1002/(SICI)1099-1050(199707)6:4<327::AID-HEC282>3.0.CO;2-W9285227
  83. Tyrer P, Salkovskis P, Tyrer H, Wang D, Crawford MJ, Dupont S, et al. Cognitive-behaviour therapy for health anxiety in medical patients (CHAMP): a randomised controlled trial with outcomes to 5 years. Health Technol Assess 2017;21(50). 10.3310/hta21500
  84. Hedman E, Andersson E, Ljótsson B, Axelsson E, Lekander M. Cost effectiveness of internet-based cognitive behaviour therapy and behavioural stress management for severe health anxiety. BMJ Open 2016;6:e009327. 10.1136/bmjopen-2015-009327
  85. Lindsäter E, Axelsson E, Salomonsson S, Santoft F, Ljótsson B, Åkerstedt T, et al. Cost-effectiveness of therapist-guided internet-based cognitive behavioral therapy for stress-related disorders: secondary analysis of a randomized controlled trial. J Med Internet Res 2019;21:e14675. 10.2196/1467531586370
  86. Fenwick E, O’Brien BJ, Briggs A. Cost-effectiveness acceptability curves – facts, fallacies and frequently asked questions. Health Econ 2004;13:405–15. 10.1002/hec.90315127421
  87. Lovell K, Bower P, Gellatly J, Byford S, Bee P, McMillan D, et al. Clinical effectiveness, cost-effectiveness and acceptability of low-intensity interventions in the management of obsessive-compulsive disorder: the Obsessive-Compulsive Treatment Efficacy randomised controlled Trial (OCTET). Health Technol Assess 2017;21(37). 10.3310/hta21370
  88. Angell C, Alexander J, Hunt JA. ‘Draw, write and tell’: a literature review and methodological development on the ‘draw and write’ research method. J Early Child Res 2015;13:17–28. 10.1177/1476718X14538592
  89. McWhirter J. The draw and write technique as a versatile tool for researching children’s understanding of health and well-being. Int J Heal Promot Educ 2014;52:250–9. 10.1080/14635240.2014.912123
  90. Ritchie J, Spencer L. Qualitative Data Analysis for Applied Policy Research. In Bryman A, Burgess R, editors. Analyzing Qualitative Data. London: Routledge; 1994. pp. 172–94.
  91. Dixon-Woods M. Using framework-based synthesis for conducting reviews of qualitative studies. BMC Med 2011;9:39. 10.1186/1741-7015-9-3921492447
  92. Tindall L, Scott AJ, Biggs K, Hayward E, Wilson J, Cooper C, et al. The Alleviating Specific Phobias in Children Trial: challenges and solutions to implementing a randomised controlled trial in clinical services. Front Child Adolesc Psychiatry 2022; in press.
  93. Department of Health and Social Care (DHSC). Future in Mind: Promoting, Protecting and Improving our Children and Young People’s Mental Health and Wellbeing. London: DHSC; 2015. URL: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/414024/Childrens_Mental_Health.pdf (accessed 9 April 2021).
  94. Department of Health and Social Care and Department for Education. Transforming Children and Young People’s Mental Health Provision: A Green Paper. 2017. URL: www.gov.uk/government/consultations/transforming-children-and-young-peoples-mental-health-provision-a-green-paper (accessed 9 April 2021).
  95. Wiles N, Thomas L, Abel A, Barnes M, Carroll F, Ridgway N, et al. Clinical effectiveness and cost-effectiveness of cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care: the CoBalT randomised controlled trial. Health Technol Assess 2014;18(31). 10.3310/hta18310
  96. National Institute for Health and Care Excellence (NICE). Guide to the Methods of Technology Appraisal 2013. London: NICE; 2013. URL: www.nice.org.uk/process/pmg9/chapter/foreword (accessed 22 March 2021).
  97. Sekhon M, Cartwright M, Francis JJ. Acceptability of healthcare interventions: an overview of reviews and development of a theoretical framework. BMC Health Serv Res 2017;17:88. 10.1186/s12913-017-2031-828126032
  98. Thompson A, Issakidis C, Hunt C. Delay to seek treatment for anxiety and mood disorders in an Australian clinical sample. Behav Chang 2008;25:71. 10.1375/bech.25.2.71
  99. Hiermeier UM, Mofrad L. Feasibility of one-session treatment for specific needle phobia in an adult IAPT service – a case series. Cogn Behav Ther 2020;13:E51. 10.1017/S1754470X2000046X
  100. Haukebø K, Skaret E, Ost LG, Raadal M, Berg E, Sundberg H, Kvale G. One- vs. five-session treatment of dental phobia: a randomized controlled study. J Behav Ther Exp Psychiatry 2008;39:381–90. 10.1016/j.jbtep.2007.09.00618005932
  101. Sands N. An exploration of clinical decision making in mental health triage. Arch Psychiatr Nurs 2009;23:298–308. 10.1016/j.apnu.2008.08.00219631108
  102. Bradby H, Varyani M, Oglethorpe R, Raine W, White I, Helen M. British Asian families and the use of child and adolescent mental health services: a qualitative study of a hard to reach group. Soc Sci Med 2007;65:2413–24. 10.1016/j.socscimed.2007.07.02517766019
  103. Hussain-Gambles M, Atkin K, Leese B. Why ethnic minority groups are under-represented in clinical trials: a review of the literature. Health Soc Care Community 2004;12:382–8. 10.1111/j.1365-2524.2004.00507.x15373816
  104. Stein SM, Christie D, Shah R, Dabney J, Wolpert M. Attitudes to and knowledge of CAMHS: differences between Pakistani and White British mothers. Child Adolesc Ment Health 2003;8:29–33. 10.1111/1475-3588.0004232797549
  105. Young A, Ferguson-Coleman E, Wright B, Le Couteur A. Parental conceptualizations of autism and deafness in British deaf children. J Deaf Stud Deaf Educ 2019;24:280–8. 10.1093/deafed/enz00230839059
  106. NHS Benchmarking Network. 2019 Child and Adolescent Mental Health Services Project – Results Published. 2019. URL: www.nhsbenchmarking.nhs.uk/news/2019-child-and-adolescent-mental-health-services-project-results-published (accessed 8 April 2021).
  107. Smith J, Kyle RG, Daniel B, Hubbard G. Patterns of referral and waiting times for specialist Child and Adolescent Mental Health Services. Child Adolesc Ment Health 2018;23:41–9. 10.1111/camh.1220732677372
  108. Young Minds. New Figures on CAMHS Waiting Times. 2018. URL: https://youngminds.org.uk/blog/new-figures-on-camhs-waiting-times/ (accessed 8 April 2021).
  109. Ludlow C, Hurn R, Lansdell S. A current review of the Children and Young People’s Improving Access to Psychological Therapies (CYP IAPT) program: perspectives on developing an accessible workforce. Adolesc Health Med Ther 2020;11:21–8. 10.2147/AHMT.S19649232104131
  110. Evans R, Thirlwall K, Cooper P, Creswell C. Using symptom and interference questionnaires to identify recovery among children with anxiety disorders. Psychol Assess 2017;29:835–43. 10.1037/pas000037527845527
  111. Albano AM, Silverman WK. The Anxiety Disorders Interview Schedule for Children for DSM-IV: Child Version. San Antonio, TX: Psychological Corporation; 1996.
  112. NHS Digital. GP Appointments Data Published. 2018. URL: https://digital.nhs.uk/news-and-events/latest-news/gp-appointments-data-published (accessed 12 February 2021).
  113. NHS England. Approved Costing Guidance 2020 for Mental Health. 2020. URL: www.england.nhs.uk/approved-costing-guidance-2020/#approved-costing-guidance-collections (accessed 12 February 2021).
  114. Flatt N, King N. Brief psycho-social interventions in the treatment of specific childhood phobias: a controlled trial and a 1-year follow-up. Behav Chang 2010;27:130–53. 10.1375/bech.27.3.130
  115. Keyes A, Gilpin HR, Veale D. Phenomenology, epidemiology, cormobidity and treatment of a specific phobia of vomiting: a systematic review of an understudied disorder. Clin Psychol Rev 2018;60:15–31. 10.1016/j.cpr.2017.12.00229277320
  116. Jensen PS, Foster M. Closing the research to practice gap in children’s mental health: structures, solutions, and strategies. Adm Policy Ment Health 2010;37:111–19. 10.1007/s10488-010-0286-z20217208
  117. Curtis L, Burns A. Unit Costs of Health and Social Care 2015. Canterbury: PSSRU, University of Kent; 2015.
  118. UNISON. National Joint Council for Local Government Services. National Agreement on Pay and Conditions of Service. 2018. URL: www.unison.org.uk/content/uploads/2018/07/NJC-Green-Book-18.pdf (accessed 10 January 2022).
  119. Office for National Statistics. Employee Earnings in the UK: 2018. 2018. URL: https://www.ons.gov.uk/employmentandlabourmarket/peopleinwork/earningsandworkinghours/bulletins/annualsurveyofhoursandearnings/2018 (accessed January 2021).
  120. Low Pay Commission. The Minimum Wage in 2018. Low Pay Commission Analysis. 2018. URL: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/695810/The_minimum_wage_in_2018_-_LPC_analysis.pdf (accessed January 2021).
← DiscussionAcknowledgements →

Attribution. Barry Wright; Lucy Tindall; Alexander J Scott; Ellen Lee; Katie Biggs; Cindy Cooper et al. (2022). One-session treatment compared with multisession CBT in children aged 7–16 years with specific phobias: the ASPECT non-inferiority RCT. National Institute for Health and Care Research. Copyright © 2022 Wright et al. This work was produced by Wright et al. under the terms of a commissioning contract issued by the Secretary of State for Health and Social Care. This is an Open Access publication distributed under the terms of the Creative Commons Attribution CC BY 4.0 licence, which permits unrestricted use, distribution, reproduction and adaption in any medium and for any purpose provided that it is properly attributed. See: http://creativecommons.org/licenses/by/4.0/. For attribution the title, original author(s), the publication source – NIHR Journals Library, and the DOI of the publication must be cited. Licensed under CC BY 4.0. NCBI Bookshelf NBK585874. CC BY 4.0. Original source ↗. Text reproduced from the Bookshelf XML without changing wording; figures, images and supplements are not reproduced.

In this chapter Contents

  • References

Source

OpenStax source file ↗

Source record ↗

EvidenceLib is a research-education resource, not medical advice. It does not diagnose, prescribe or recommend starting, stopping or changing any treatment. Talk to a qualified clinician about your own situation. Methods, sources and licences · Rights and removal requests · Legal · Support